Cargando…
Structural Insights into the Mechanism of a Nanobody That Stabilizes PAI-1 and Modulates Its Activity
Plasminogen activator inhibitor-1 (PAI-1) is the main physiological inhibitor of tissue-type (tPA) and urokinase-type (uPA) plasminogen activators (PAs). Apart from being critically involved in fibrinolysis and wound healing, emerging evidence indicates that PAI-1 plays an important role in many dis...
Autores principales: | Sillen, Machteld, Weeks, Stephen D., Strelkov, Sergei V., Declerck, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461574/ https://www.ncbi.nlm.nih.gov/pubmed/32824134 http://dx.doi.org/10.3390/ijms21165859 |
Ejemplares similares
-
Structural Insight into the Two-Step Mechanism of PAI-1 Inhibition by Small Molecule TM5484
por: Sillen, Machteld, et al.
Publicado: (2021) -
Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition
por: Sillen, Machteld, et al.
Publicado: (2020) -
A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target?
por: Sillen, Machteld, et al.
Publicado: (2021) -
Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review
por: Sillen, Machteld, et al.
Publicado: (2021) -
Structural Insights into the Design of Synthetic Nanobody Libraries
por: Valdés-Tresanco, Mario S., et al.
Publicado: (2022)